DaVita Venture Group builds partnerships with health care innovators to improve the lives of patients with kidney disease and related conditions.

DaVita Venture Group

Driving innovation for DaVita through venture investments, partnerships, M&A, and pharma contracting. 

A huge welcome to our team's new paralegal, Dava Reynolds! ✨ Our legal work is such an integral part of our partnerships, contracting, and investments in the DaVita Venture Group. We are thrilled to partner with you and work with you, Dava! 

Allison Donovan

We are so excited to welcome our two interns for the summer through the DaVita Kidney Care Redwoods program: 

Blake Niehaus joins us from his Wharton MBA and was previously in private equity at Arsenal Capital Partners and Audax Group. 
Kate Williams joins us from her Texas Christian University undergrad and interned in consulting last summer.

We are looking forward to learning with and from you this summer!

We are thrilled to welcome our newest DaVita Kidney Care Executive partner, Joel Haugen, who joined a few weeks ago. DaVita is increasingly become a tech-enabled, product-focused organization. And we couldn't imagine a better leader to lead this function for DaVita, blending his experience from Signify Health, Crossover Health, Optum, and Accenture to deepen our strategic approach and product roadmap. 

DVG is excited to partner with you and learn from you, Joel!

Our team does what it does with the support and partnership of our DaVita Kidney Care leaders. We're thrilled to continue to partner with our new Chief Information Officer, Madhu Narasimhan, who has already made her mark at DaVita. 

Madhu brings incredible depth and passion from her roles leading IT at Wells Fargo and Kaiser Permanente. We can't wait to partner with you!

Congratulations to Heartbeat Health on its Series C investment led by Cressey & Company. We are excited to be doubling down alongside Echo Health Ventures, Kindred Ventures, Optum Ventures, and DaVita Venture Group in this game-changing company!

.406 Ventures led Heartbeat’s Series A in February 2020 (just before Covid and the proliferation of virtual care). Even then, we saw the potential for HBH to leverage world-class clinical expertise to become the largest virtual cardiovascular care provider in the US. This new funding will solidify that position and allow the company to expand access to even more patients who will benefit from this level of care.

Heartfelt congrats to Jeffrey Wessler, David Dempsey, Jana M. Goldberg, MD, FACC, Brian Greer, Saiba Sabherwal, Andrew MacGill, Anthony Castillo, and the whole team! ❤️ 

Payal Agrawal Divakaran, Liam Donohue, Rebecca Redfield, Trip Hofer


https://lnkd.in/eqStFFip

Metric
Company Name	DaVita Venture Group
Symbol
MSH ID	COM:DAVITAVENTUREGROUP
Market	PRIVATE
Sector	Healthcare & Health Services
Industry	Healthcare Investment
Country	US
Stage
Employee Count	13
Website	davitaventuregroup.com
LinkedIn	davita-venture-group
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic
Web Traffic Growth
Valuation
Raised Capital

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

DAVI

COM:DAVITAVENTUREGROUP

DaVita Venture Group

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue